Citigroup Inc Olink Holding Ab (Publ) Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$21.87 - $25.59 $336,798 - $394,086	15,400 Added 102.67%	30,400 $774,000
Q1 2024 May 10, 2024	BUY	$21.81 - $25.14 $327,150 - $377,100	15,000 New	15,000 $352,000
Q1 2023 May 11, 2023	BUY	$19.34 - $24.11 $23,614 - $29,438	1,221 Added 1565.38%	1,299 $29,000
Q4 2022 Feb 09, 2023	SELL	$12.64 - $25.52 $29,615 - $59,793	-2,343 Reduced 96.78%	78 $1,000
Q3 2022 Nov 10, 2022	BUY	$12.14 - $18.42 $28,395 - $43,084	2,339 Added 2852.44%	2,421 $29,000
Q2 2022 Aug 10, 2022	SELL	$8.95 - $19.24 $4,475 - $9,620	-500 Reduced 85.91%	82 $1,000
Q1 2022 May 12, 2022	BUY	$11.33 - $19.3 $5,041 - $8,588	445 Added 324.82%	582 $10,000
Q4 2021 Feb 10, 2022	BUY	$18.0 - $34.82 $2,466 - $4,770	137 New	137 $2,000

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.